Emily Kaiser Maharjan, Assistant Managing Editor

Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.

The dry eye drug has been assigned a PDUFA decision date of April 2, 2025, and the Aldeyra has chosen to expand their exclusive option agreement with AbbVie.

Gromacki, OD, FAAO, FSLS, emphasizes that corneal GP lenses remain an important part of a contact lens specialist's armamentarium

Susan Gromacki, OD, MS, FAAO, FSLS, details a panel that provided a complete course on keratoconus.

In a study, a xenon slide illuminator was employed to mimic natural outdoor colors, allowing researchers to test brightness perception using a brightness-matching method, explains Billy R. Hammond.

ODs share what they learned at this year's Academy meeting and what they plan to take home to their practices.

Tracy Doll, OD, FAAO, details portions of the Tear Film and Ocular Surface Society Lifestyle Report, which discussed certain risk factors that we may have for development of ocular surface dryness or dry eye.

Dana Shannon, OD, FAAO, details The Contact Lens Institute's latest report, "Disrupting the Dropout Dilemma."

At the 2024 American Academy of Optometry meeting in Indianapolis, Dr Andrew Pucker describes a wealth of data on enrollment in North American clinical trials.

Steve Ferrucci, OD, FAAO, discussed the detection and treatment of geographic atrophy during his AAOpt 2024 lecture, "Imaging Techniques and Emerging Therapies for Geographic Atrophy."

Jessilin Quint, OD, MBA, MS, FAAO, gives an overview on next steps after treating dry eye

Alongside Walt Whitley, OD, MBA, FAAO, Ahmad Fahmy, OD, FAAO, gave a presentation entitled, "Management of Neurotrophic Keratitis and Corneal Neuropathic Pain," at this year's AAOpt meeting.

Raman Bhakhri, OD, FAAO, breaks down the complex process of diagnosing inherited retinal diseases.

Erin Tomiyama, OD, PhD, FAAO, discusses fitting lenses, young adults with binocular vision issues, and emerging presbyopia in patients.

Dr. Carolyn Majcher discusses her 2024 AAOpt talk on imaging techniques and emerging therapy for geographic atrophy.

Brooke Messer, OD, FAAO, FSLS, overviews a talk on keratoconus management.

Mila Ioussifova, OD, CNS, FAAO, FOWNS, tackled new and exciting ways to tackle meibomian gland dysfunction alongside fellow ocular surface specialist Rana Taji, OD, MSc, FAAO, at AAOpt 2024.

In an AAOpt poster, Dr. Mark Bullimore investigates the definition of "normal progression" in myopic eyes and the change of efficacy over time.

At AAOpt, Dr. Justin Schweitzer talks about myths surrounding ocular surgery and comanagement of surgical patients.

Dr. Andrew Pucker presented data on the performance of toric lenses under the stress of heavy digital device use at the 2024 American Academy of Optometry meeting in Indianapolis.

The presentation covers different retinal conditions and diseases and how to utilize collaboration in order to enhance patient care.

Justin Schweitzer, OD, FAAO; Selina McGee, OD; and Ian Ben Gaddie, OD, FAAO; delve into how optometry has changed in the past year.

Dr. Carolyn Majcher's lecture on posterior uveitis reinforced the need for optometrists to be vigilant in their diagnostic approach.

Graham Erickson, OD, FAAO, FCOVD, states that maintaining eye and brain health through proper nutrition, whether through diet or supplementation, can have a significant impact on various aspects of sports performance.

Dr. Justin Schweitzer's 2024 AAOpt talk will cover the latest advancements in ocular drug delivery, including topical, implant, and contact lens-based methods that can improve patient quality of life, adherence, and financial burden.

Erin Rueff, OD, PhD, FAAO, details the presentation she gave at this year's conference on the importance of validating patients' symptoms in cases of neuropathic corneal pain.

Julie Rodman, OD, MS, FAAO, details a Rapid Fire session she presented at this year's American Academy of Optometry meeting, which features a case study on retinal vein occlusion.

The lipid-containing lubricating drop established noninferiority in comfort when compared to non-lipid drops, and the lipid-containing group also exhibited statistically significant improvements in visual quality at both day 7 and day 30, highlighting the potential benefits of this formulation for patients.

At the Tear Film and Ocular Surface meeting in Venice, Dr. Melissa Toyos shares findings on the mechanism of action of brimonidine tartrate.

New research sheds light on how the dry eye medication lifitegrast works beyond the ocular surface, targeting the underlying immune system to provide relief for patients.